South Africa's pharmacists have been warned not to substitute drugs illegally as "it could do the profession a great deal of harm." The warning by Cecil Abramson, president of the Pharmaceutical Society of South Africa, follows complaints by the Pharmaceutical Manufacturers Association of South Africa to the country's Pharmacy Council and the PSSA that such illegal substitution occurs "in response to financial incentives offered to pharmacists," and not because of the interests of patients.
Mr Abramson said that while the PSSA supports substitution and is doing its level best to achieve the urgently-needed flexibility for pharmacists, especially under pressure from medical aides, the association cannot condone illegal behavior.
He reminded pharmacists that the SA Pharmacy Council will take disciplinary action on receipt of complaints relating to illegal substitution, and that "politicians, doctors and others are just waiting for a reason to attack the profession, which could in turn lead to additional hurdles in getting access to the higher schedules." "Illegal substitution of products because of lucrative deals received from manufacturers is irresponsible, and is placing the profession in a precarious position," he warned.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze